The decision by India to sanction two vaccines-Serum Institute’s Covishield and Bharat Biotech’s Covaxin-is a landmark moment in its battle against COVID-19, Health Minister Dr Harsh Vardhan tweeted this afternoon, shortly after a significant announcement was made by the DCGI drug regulator. He dedicated the two vaccines to those who were at the forefront of India’s war against highly infectious disease.
“A watershed moment in India’s famed battle against #COVID19 under the charismatic leadership of Hon’ble PM Sh @narendramodi Ji ! Our wait for #COVID19vaccine is over with COVISHIELD from @SerumInstIndia & COVAXIN from @BharatBiotech approved for emergency use in India @PMOIndia,” Dr. Harsh Vardhan tweeted this afternoon.
“These vaccines are a fitting tribute to our corona warriors! My heartfelt gratitude to all healthcare professionals & frontline workers for their exemplary efforts during these unprecedented times. Congratulations to all the scientists & researchers for their untiring efforts,” he wrote in another post. https://twitter.com/drharshvardhan/status/1345637786125103105?s=20
The Health Minster, yesterday, had said free coronavirus vaccines will be given in the first phase to three crore people who have been on the frontline in the fight against the highly contagious disease.”
